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Introduction: Recently settled refugee populations have consistently been reported to have high rates of mental
health problems, particularly Post-traumatic stress disorder, depression, and anxiety disorders. The aim of this study
was to investigate psychotropic drug use among young adult refugees according to duration of residence during
the first 10 years in Sweden.
Methods: Cross-sectional register study of a national cohort of 43 403 refugees and their families (23–35 years old)
from Iraq, Iran, Eritrea, Ethiopia, Somalia and Afghanistan and a comparison population of 1.1 million Swedish-born
residents. Logistic regression was used to assess the association between duration of residence in Sweden and the
dispensing of at least one psychotropic medication during 2009 in four categories (any drug, neuroleptics,
antidepressants and anxiolytics/hypnotics), adjusting for age, gender and domicile.
Results: Rates of dispensed psychotropic drugs among recently settled refugees were low, compared to the
Swedish-born, with an increase with duration of residence. For refugee men and women from Iraq/Iran who had
resided for 0–3 years the adjusted ORs compared to Swedish natives, were 0.83 (95% CI 0.77-0.90) and 0.48 (0.44-0.53)
respectively; for men and women from the Horn of Africa the ORs were 0.50 (0.42-0.61) and 0.36 (0.30-0.41) respectively.
After 7–10 years of residence, the ORs in these refugee groups approached the Swedish comparison population.
Refugees from Afghanistan presented ORs similar to the Swedish-born, with no consistent trend by duration of
residence. Women from the Horn of Africa and Iraq/Iran consumed less psychotropic drugs compared with men from
these regions of origin, relative to the Swedish-born (p < 0.01). The ORs for dispensed neuroleptics were similar
between the different refugee study groups, while the ORs for dispensed antidepressants differed fourfold between the
group with the lowest (Horn of Africa) and the highest (Afghanistan).
Conclusion: The rates of dispensed psychotropic drugs in the newly settled refugee populations in this study were
low, with an increase with longer duration of residence. This pattern suggests barriers to access mental health care.
Interventions that can lower these barriers are needed to enable newly settled refugees to access mental health care
on equal terms with the native population.
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Refugees have made up a large share of the immigrants to
Scandinavia in recent decades. This is particularly true for
Sweden, which since 1980 has received about 560 000 ref-
ugees and their families, primarily young adults and their
children [1]. Pre-migration stress associated with war and
political persecution in the country of origin, and long pe-
riods of uncertainty during the asylum process constitute
potent risk factors for the development of mental health
problems in refugees [2]. A systematic review of mental
health in refugees, including studies of 7000 refugees
resettled in Western countries, estimated the prevalence
of Post-traumatic stress disorder (PTSD) to 8-10%, or about
ten times the rate in the general population [3]. Other stud-
ies have additionally found elevated levels of depression
[4,5]. In a Danish register-based study, refugees were found
to have higher risk of having a first-time psychiatric contact
for psychotic, affective and nervous disorders, compared
with the native population [6]. Longitudinal studies of men-
tal health in refugees showed slowly decreasing levels of
psychiatric problems over time [7,8], albeit levels remained
on a higher level than the majority population for as long
as two decades after resettlement [9].
Despite this higher level of mental health problems,
studies on utilization of mental health care service
among refugees and immigrants showed lower use com-
pared with natives, as well as different utilization patterns
[10]. Studies on the use of somatic health care services
among refugees and immigrants showed that service
utilization increased with length of stay in the country and
became more similar to the pattern of the majority popu-
lation [11]. This suggests that newly arrived refugees and
immigrants are confronted with barriers when accessing
health care related to both structural and individual fac-
tors including organization of services as well as language
and socio-cultural dimensions, which are gradually over-
come with the process of adaptation to the new society.
Studies on use of psychotropic drugs in refugees and im-
migrants are rare in the literature [12-16]. Some register-
based studies applied psychotropic medication as a proxy
for mental health [14], while others also investigated ac-
cess to treatment [15]. In a Swedish study on psychotropic
drug use among 18-years old adolescents, descendants of
immigrant women were found to have a lower use of
medication, than the offspring of native Swedish women,
despite assumed higher needs. The differences were most
pronounced regarding the offspring to women from low-
income countries, which was also the immigrant group
with shortest time spent in Sweden [15]. Studies on anti-
depressant treatment showed that minority groups were at
increased risk of not receiving adequate pharmacological
therapy for depression compared to majority population,
with immigrants presenting higher risk of not initiate
treatment after having a prescription fulfilled [17], as wellas of early discontinuation of treatment [18]. However,
there were also studies reporting higher psychotropic drug
use among immigrants compared with natives [12-14,16].
In a Swedish survey of immigrants from five different coun-
tries 5–15 years after settlement, for instance, immigrants
generally reported a higher psychotropic drug use com-
pared with Swedish-born. The difference regarding anti-
depressant was accounted for by a higher morbidity among
the immigrants [12], while the higher use of anxiolytics and
hypnotics seemed to be a result of differences in prescrip-
tion patterns of doctors to immigrant patients compared
with native patients, rather than a higher morbidity [13].
Although time in the new country has shown to be import-
ant when studying access to health care services [11], as
well as immigrant and refugee mental health [7-9], no study
on psychotropic medication among immigrants did focus
specifically on the time aspect, or on psychotropic drug use
in newly arrived refugees.
Considering that migration is an ongoing process with
time as an important factor for both health and health
care utilization, the aim of this study was to investigate
the association between duration of residence and psy-
chotropic drug use among refugees and their families
who had been residents in Sweden during 1–10 years.
We also studied whether psychotropic drug use in refu-
gees differed by gender and region of origin.
Method
This study was a cross-sectional, register study based on
data from the Prescribed Drug Register held by the
Swedish National Board of Health and Welfare and the
Register of the Total Population held by Statistics Sweden.
Data from the two registers was linked through the unique
personal identification number assigned to each individual
at birth or on obtaining residence permission in Sweden.
The study was carried out with ethical approval from the
Regional Ethical Committee in Stockholm.
Study population
The index population was defined as all individuals
born between 1973 and 1985, who immigrated to
Sweden between 1998 and 2008 (thus with an age at im-
migration of 13–34 years) from Iraq, Iran, Eritrea,
Ethiopia, Somalia or Afghanistan (n = 43 403), who
remained as residents in Sweden in 2008. All Swedish-
born residents, including descendents to immigrants, in
these birth cohorts were included as a comparison
population (n = 1 144 075). International adoptees (n =
60) and individuals missing information on domicile
(n = 3 029) were excluded. The countries of birth of the
immigrants included in the study all have a history of
war, political turmoil and/or oppression and consisted
of the large majority of refugees granted asylum during
these years [19], which makes it reasonable to assume
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population were refugees or relatives to refugees.
Outcomes
Information on use of psychotropic medication was ob-
tained from the Swedish Prescribed Drug Register dur-
ing 2009, which holds information on all drug
prescriptions dispensed from Swedish pharmacies, ex-
cluding medical drugs consumed in inpatient hospital
care. The outcome was defined as at least one dis-
pensed, prescribed psychotropic drug during 2009 in
the pharmaceutical ATC categories: a) neuroleptics
(N05A), b) antidepressants (N06A), c) anxiolytics/hyp-
notics (N05B and N05C) or d) any psychotropic drug
(at least one of the three categories). Anxiolytics and
hypnotics were analyzed together as there is a broad
overlap in the conditions for which they are used.
Co-variates
Information on date of birth, gender, country of origin,
year of immigration and domicile was obtained from the
Register of the Total Population. Year of immigration
was defined as the year of the last time the individual re-
ceived residence permit for a minimum of one year in
Sweden. Duration of residence was defined as the differ-
ence between the year of immigration and the year of
study (2009). Domicile was categorized as metropolitan
(Stockholm, Göteborg, Malmö), other city, and rural,
based on the characteristics of the municipality.
Statistical analysis
Logistic regression models were used to investigate the as-
sociation between time in Sweden and psychotropic drug
use. The outcomes were four binary variables (dispensing
of drugs or not in 2009 in the categories described above).
Due to the sample size, duration of residence was divided
into three categories (0–3, 4–6, 7–10 years), considering
the pattern of a non-linear increase in prevalence of psy-
chotropic drug use with duration of residence evident
from non-adjusted data. Based on their geographical loca-
tion and economic characteristics, the regions of origin
were grouped into Iraq/Iran, the Horn of Africa and
Afghanistan. In a first analysis, a gender stratified logistic
regression model was used to analyze the association be-
tween any dispensed psychotropic drug and duration of
residence in three refugee study groups with the Swedish-
born population as a reference category, adjusting for age
and domicile.
In a second analysis, to investigate the association be-
tween duration of residence and specific psychotropic
drug use, one logistic regression model was performed
for each of the four categories of psychotropic drugs in
the refugee population, with refugees from Iraq/Iran as
the reference group, adjusting for age, gender, durationof residence and domicile. Age was introduced as a con-
tinuous variable in both analyses since there was a linear
relation between age and all outcomes.
An interaction analysis of gender in the three refugee
groups was made in a logistic regression model of hav-
ing at least one dispensed psychotropic drug relative to
the Swedish comparison group, with adjustment for age
and domicile.
Statistical analyzes were performed using SPSS Statis-
tics 20.
Results
Table 1 shows demographic characteristics of the study
population. Iraqis constituted more than half of the refu-
gee group. Women formed the majority in the refugee
groups from the Horn of Africa and Iran, while the op-
posite was true for Iraq and Afghanistan. There were
small differences in mean duration of residence and also
in age between the different nationalities. Age was also
evenly distributed in relation to duration of residence,
with refugees who had been 0–3 years in Sweden being
less than one year younger than those who had been 7–
10 years in Sweden (results not shown in table).
Table 2 presents percentages of the four outcomes in
2009 by country of birth and duration of residence. The
rates of having dispensed at least one psychotropic drug
varied from 3.7% in the male group with the lowest rates
(Eritrea) to 7.7% in male refugees from Afghanistan and
the Swedish-born comparison population and from 3.6%
(Ethiopia) to 12.6% (Afghanistan) in the female refugees.
Figure 1 demonstrates the rates of dispensed pre-
scribed drugs in 2009 among refugees by duration of
residence (1–10 years). Refugees with a duration of resi-
dence of 10 years had a similar rate of having at least
one dispensed psychotropic drug compared with the
Swedish-born. This pattern was relevant for neuroleptic
drugs, as well as for anxiolytics/hypnotics, while levels
of antidepressants remained lower also in refugees with
10 years of residency.
Table 3 presents gender stratified odds ratios (ORs) for
having any dispensed psychotropic drug in 2009 by dur-
ation of residence and refugee group, compared with the
Swedish-born population. Refugee men from Iraq/Iran,
with a short duration of residence (0–3 years) had slightly
lower ORs compared to the Swedish-born men 0.83 (95%
CI 0.77-0.90), while for refugee men from the Horn of
Africa, ORs were much lower for men with 0–3 years;
0.50 (95% CI 0.42-0.61), as well as 4–6 years of residence;
0.44 (0.28-0.68). For refugee women from Iraq/Iran and
the Horn of Africa ORs were considerably lower than
among the Swedish comparison group for all durations of
residence, with a tendency to increase with longer dur-
ation; from 0.48 (95% CI 0.44-0.53) for 0–3 years to 0.72
(95% CI 0.65-0.80) for 7–10 years for women from Iraq/
Table 1 Demographic characteristics of the refugee population and the Swedish-born comparison group
Country of birth N Male sex (%) Mean age (years) Mean duration of residence (years)
Iraq 24 885 55.0 28.9 3.8
Iran 6 476 43.6 28.8 3.6
Eritrea 1 780 39.4 30.0 2.5
Ethiopia 1 620 40.9 29.4 3.2
Somalia 5 811 43.1 28.3 3.0
Afghanistan 2 831 56.5 29.9 4.2
Sweden 1 144 075 51.7 29.1 -
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0.66), respectively for women from the Horn of Africa. The
refugees from Afghanistan had more similar adjusted ORs
compared with the Swedish comparison population with
no consistent trends by duration of residence. Refugee-
women from Iraq/Iran and the Horn of Africa had lower
adjusted ORs than men compared with the same gender in
the Swedish comparison population. This gender pattern
was confirmed in an interaction analysis, which showed a
lower consumption of psychotropic drugs in women from
Iraq/Iran and the Horn of Africa relative to men in com-
parison with Swedish-born of the same gender (p < 0.01)
Table 4 shows a refugee specific logistic regression ana-
lysis in both genders of different types of psychotropic
drugs with Iraq/Iran as the comparison group, adjusting for
duration of residence. For neuroleptic drugs there were no
differences between the refugee study groups, while for an-
tidepressants the adjusted ORs differed greatly from 0.36
(95% CI 0.31-0.43) for refugees from the Horn of Africa
and 1.49 (95% CI 1.16-1.76) for refugees from Afghanistan.
The pattern was similar for anxiolytic/hypnotic drugs with
adjusted ORs of 0.63 (95% CI 0.56-0.71) and 1.23 (95% CI
1.05-1.44) respectively.Table 2 Percentage of psychotropic drug use in 2009 by coun
Men N Women N Any drug Neur
M (%) W (%) M (%
Country of birth
Iraq 13 699 11 186 7.1 7.2 1.2
Iran 2 824 3 652 7.4 9.6 1.0
Eritrea 701 1 079 3.7 5.0 0.9
Ethiopia 662 958 4.0 3.6 0.9
Somalia 2 504 3 307 4.5 5.6 1.1
Afghanistan 1 600 1 231 7.7 12.6 1.2
Sweden 590 505 550 573 7.7 12.5 1.1
Duration of residence
0-3 years 13 960 11 568 6.1 6.2 0.9
4-6 years 3 378 4 687 7.7 8.4 1.5
7-10 years 4 652 5 158 7.7 9.1 1.5Discussion
In this study of psychotropic medication in a national
cohort of more than 40 000 young adult refugees and
their families in Sweden, we found lower rates of dis-
pensed psychotropic drugs among recently settled refu-
gees, compared to Swedish-born, with an increase with
duration of residence. The adjusted ORs for having dis-
pensed at least one psychotropic drug during 2009 were
lower for refugees from Iraq/Iran and the Horn of Africa
who had resided for 0–3 years compared with native
Swedish residents, while the adjusted ORs were more
similar for those with 7–10 years of residency. Afghans
had more similar ORs compared with the Swedish-born,
and refugee women generally had lower ORs compared
with refugee men relative to the native Swedish residents.
Refugees from the Horn of Africa presented lower ad-
justed ORs of antidepressants and axiolytics/hypnotics
compared with the other refugee groups, while the use of
neuroleptic drugs was similar between refugee groups.
It is reasonable to believe that levels of drug consumption
may reflect both mental health status as well as access to
care. As mentioned above, high levels of PTSD and depres-
sion have been consistently reported in refugee populationstry of birth and duration of residence
oleptics Anti-depressants Anxiolytics/hypnotics
) W (%) M (%) W (%) M (%) W (%)
0.7 4.0 4.3 5.4 5.4
0.8 4.2 6.2 5.0 6.4
0.4 2.4 2.0 2.3 3.7
1.0 2.1 1.8 2.7 2.7
0.8 4.4 1.5 3.3 4.4
1.2 4.4 8.5 5.3 7.9
1.1 5.2 9.3 4.6 7.0
0.6 3.2 3.4 4.7 4.7
1.0 4.2 5.1 5.0 5.8
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Figure 1 Percentage of psychotropic drug use in refugees
compared with Swedish-born. a) Any drug b) Neuroleptics
c) Antidepressants d) Anxiolytics/hypnotics.
Table 3 Psychotropic drug use among refugees
(n = 43 403) and Swedish-born (n = 1 144 075)
Any drug
Men OR (95% CI) Women OR (95% CI)
Region of origin and duration of residence
Sweden 1 1
Iraq and Iran 0-3 years 0.83 (0.77-0.90) 0.48 (0.44-0.53)
4-6 years 1.03 (0.89-1.19) 0.69 (0.61-0.78)
7-10 years 1.04 (0.93-1.17) 0.72 (0.65-0.80)
Horn of Africa 0-3 years 0.50 (0.42-0.61) 0.36 (0.30-0.41)
4-6 years 0.44 (0.28-0.68) 0.35 (0.26-0.46)
7-10 years 0.84 (0.57-1.23) 0.50 (0.39-0.66)
Afghanistan 0-3 years 0.96 (0.74-1.25) 1.19 (0.92-1.53)
4-6 years 1.58 (1.14-2.18) 1.03 (0.76-1.38)
7-10 years 0.67 (0.43-1.05) 0.86 (0.61-1.21)
Age (years) 1.03 (1.03-1.03) 1.03 (1.03-1.03)
Domicile
Metropolitan 1 1
Other city 0.95 (0.93-0.97) 0.99 (0.98-1.01)
Rural 0.91 (0.88-0.93) 0.97 (0.95-1.00)
Brendler-Lindqvist et al. International Journal for Equity in Health  (2014) 13:122 Page 5 of 9[3-6]. This is true also for recent studies of the newly settled
refugees in the population in focus in this study [5,20,21].
In a study on 366 newly settled Iraqi refugees (age 18–84
years old) to the United States 18–36 months post-arrival
the prevalence of depression was estimated to 50%, and
31% of participants were identified as at risk for PTSD [5].
A study on asylum-seekers and refugees from Afghanistan,
Iran and Somalia (mean age 37 years) with on average
5.6 years since arrival in the Netherlands, reported
symptoms of PTSD in 28.1% of asylum-seekers and
10.6% of refugees, and symptoms of depression/anxiety
in 68.1 and 39.4% respectively [21]. The highest rate of
PTSD-symptoms was found in Iranian asylum-seekers
(43.4%), and the lowest rate in Afghan and Somali refu-
gees (6.0 and 4.0% respectively). For depression and
anxiety symptoms, again, the lowest rates were found in
Afghan and Somali refugees (28.9 and 16.7% respectively).
A study on 180 Somali refugees (mean age 40.4 years)
who had been living in the United Kingdom for an average
of 8 years, reported a rate of depression and/or anxiety-
symptoms of 25%, with the recently arrived refugees pre-
senting the highest levels of disorder [20]. Thus, it seems
most likely that the rates of medication found in the refu-
gees in this study are low in relation to their burden of
mental ill-health. The time pattern found in the studies
mentioned above [7-9], with the highest rates of mental
disorder in the recently settled refugees, contrasts with the
low rates of dispensed drugs during these years in our
Table 4 Psychotropic drug use among refugees by duration of residence, gender, age, country of birth and domicile
Any drug OR (95% CI) Neuroleptics OR (95% CI) Antidepressants OR (95% CI) Anxiolytics/hypnotics OR (95% CI)
Duration of residence
0-3 years 1 1 1 1
4-6 years 1.25 (1.13-1.37) 1.54 (1.20-1.97) 1.31 (1.15-1.48) 1.09 (0.97-1.22)
7-10 years 1.28 (1.17-1.40) 1.50 (1.19-1.89) 1.30 (1.15-1.46) 1.15 (1.03-1.27)
Gender
Male 1 1 1 1
Female 1.13 (1.05-1.22) 0.66 (0.54-0.81) 1.21 (1.10-1.34) 1.12 (1.03-1.22)
Age 1.06 (1.05-1.08) 1.05 (1.02-1.08) 1.08 (1.06-1.09) 1.06 (1.05-1.07)
Region of origin
Iraq and Iran 1 1 1 1
Horn of Africa 0.63 (0.56-0.70) 0.96 (0.75-1.23) 0.36 (0.31-0.43) 0.63 (0.56-0.71)
Afghanistan 1.40 (1.22-1.60) 1.19 (0.83-1.71) 1.49 (1.16-1.76) 1.23 (1.05-1.44)
Domicile
Metropolitan 1 1 1 1
Other city 0.88 (0.81-0.95) 0.73 (0.59-0.90) 0.86 (0.78-0.96) 0.84 (0.77-0.92)
Rural 1.20 (1.02-1.41) 0.81 (0.49-1.33) 1.21 (0.98-1.51) 1.08 (0.88-1.31)
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of dispensed drugs in our study as being more dependent
on a lower access to care than on a better health status.
There are both formal and informal barriers to health
care that might be relevant to understand this pattern
[22]. Formal barriers refer to organizational aspects of
the healthcare system. In Sweden, all individuals with a
residence permit are entitled to universal health care on
equal terms. According to Swedish law, asylum-seekers
and newly arrived refugees should be offered a health
examination of physical and mental health, as well as in-
formation about the Swedish health system [23], however,
only 54% of asylum-seekers underwent the examination in
2011 [24]. For newly arrived refugees and family members
who did not go through the asylum reception system the
figure was even lower. Moreover, although Swedish
health care are mainly tax-financed, there are elements
of user payment that may constitute barriers to people
with very low income levels, such as newly settled refu-
gees. In 2009 patients paid the whole cost for drugs up
to 900 SEK/year (≈88 EURO), thereafter purchase was
partially subsidized up to a maximum of 1800 SEK/year
(≈176 EURO), after which all costs were paid by the
county council [25]. The eventual effect of co-payment
for utilization is difficult to estimate, but Danish studies
have shown that costs may have some influence of drug
use among economically weak groups [26]. Informal
barriers include aspects such as knowledge about the
health system, language skills and socio-cultural factors
affecting the self-perceived needs and health seeking-
behavior [10,11,27]. Language barriers constitute a
major obstacle for newly settled refugees in contactswith the health care system [27,28]. Access to profes-
sional interpreters with training in medical terminology is
essential for effective communication, however lack of
skilled interpreters and organizational problems restrict its
use, compromising the delivery of quality care [28]. In
addition to language, communication is also affected by
cultural differences, as culture influences the concepts and
explanatory models surrounding health and illness and the
way in which mental health problems are expressed
[10,27,29]. Acculturation, the process of integration of
concepts and beliefs from the new society, is thus an im-
portant aspect of care-seeking patterns for mental health
problems in refugees [10]. As pointed out by Ingleby [27],
attitudes towards mental health among non-western im-
migrants are usually constructed in a context in the coun-
try of origin where few services are available and the
concept of mental illness often is limited to extreme dis-
turbances and associated with considerable stigma. Lack
of cultural awareness among health care professionals may
affect the interpretation of symptoms and thereby delay
or compromise the quality of diagnosis and treatment
[15,30]. The results of the study on Somali refugees in the
UK made by Bhui et al. [20], mentioned above, suggests
that there may be important differences in barriers to care
between Sweden and the UK for refugees. In the UK study
approximately 14% of the Somali refugees were taking
psychotropic medication, a considerably higher number
than the rates of psychotropic medication found in our
data (4.5 and 5.6% in the Somali men and women respect-
ively). Thus, comparative studies between refugees in dif-
ferent societies are indicated to shed further light on the
barriers to care for refugees.
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and post-migration factors. The relative influence of the
pre-migration traumatic experiences and exile-related fac-
tors may change during the migration process [31], al-
though some studies stressed that the negative impact of
severe past trauma tended to persist over time [8]. Some
studies also stressed the role of post-migration factors in
moderating the effect of pre-migration trauma, where a
continued stress in exile may prevent the process of recov-
ery from psychological problems, thus maintaining a high
load of mental ill-health over time [31].
A striking feature of the results was the variation in
dispensed prescriptions by region of origin, with refugees
from the Horn of Africa showing significantly decreased
ORs of dispensed, prescribed antidepressants and anxio-
lytics/hypnotics, compared with refugees from Iraq/Iran,
while levels were elevated among Afghans. This pattern
to a certain extent may reflect differences in prevalence
of psychiatric disorders, since a similar pattern was ob-
served in studies among asylum-seekers and refugees
from Iran, Afghanistan and Somalia in the Netherlands,
where Somalis were found to have lower rates of PTSD
and depression/anxiety symptoms, as well as having a
lower use of mental health services and psychotropic
drug, compared with other refugee populations [32]. An-
other possibility is that these differences reflect different
manners of expressing mental health problems in differ-
ent cultural contexts, rather than differences in disorders
per se [27]. Afghan men and women differed from the
other refugee groups, by presenting similar levels of psy-
chotropic drug use as the Swedish-born population
already during the first years after settlement, however,
the study population was too small to allow for any firm
conclusion for the time pattern of drug consumption for
this refugee group.
The use of neuroleptic drugs was similar between refu-
gee groups. One explanation for this may be that neuro-
leptics are prescribed for more severe conditions, often
involving psychotic symptoms, where the need for psy-
chiatric treatment is more obvious, and often initiated
by other people than the patient him/herself. Refugee
women are generally found to present higher prevalence
of depression, as well as PTSD [21,33]. Thus, the rela-
tively low levels of psychotropic drug use among refugee
women from the Horn of Africa and Iraq/Iran found in
this study are noteworthy and indicate that there may be
additional barriers to care affecting female refugees. Lan-
guage problems, because of less involvement with the
surrounding society through employment, may be one
such factor [10]. Another explanation might be a lack of
recognition of the specific experiences of refugee women
[34], with the consequence that the traumas and symp-
toms of mental illness among female refugees are over-
seen within the health care system.Strengths and limitations
The major strength of the study was that it employed
national register data covering the entire Swedish popula-
tion, avoiding the risk of biased results due to selective at-
trition and/or recall bias, which is a common problem in
surveys of minority populations [13]. The large population
sample made it possible to analyze time patterns across dif-
ferent outcomes and among groups with different origin.
Some studies in the literature have used psychotropic
drug use as indicators of mental health problems in refu-
gees and immigrants. The time dependent pattern of
drug use in this study implies considerable caution in
the interpretation of such studies, unless the relation be-
tween drug use and mental health has been investigated
in that specific population in a longitudinal perspective.
The register-based design of this study comes with the
inherent limitations of all such studies of relying on data
which was collected for purposes other than the present
research, which restricts the possible questions to be
posed and conclusions drawn.
Firstly, since we did not have information about the ac-
tual mental health status of the study population, we can-
not draw any final conclusions on the reason behind the
increase in psychotropic medication with duration of resi-
dence. Thus, we cannot completely rule out the possibility
that the increased drug use over time, besides an improved
access, to some extent also reflects deteriorating mental
health. Neither can we estimate to what extent the vari-
ation of drug use between refugee populations reflects dif-
ferences in the prevalence of mental health problems
rather than different patterns in care-seeking behavior and
barriers to care. Studies with information on psychiatric
disorders and drug use in refugees are needed to shed fur-
ther light on these patterns.
Secondly, the Swedish registers lack reliable informa-
tion on pre-migration factors regarding education and
domicile (rural/urban), as well as reason for migration.
In this study, country of origin was used as a proxy for
refugee status, which means the study population may
also include individuals migrating for other reasons than
refugee, however, this number was assumed to be negli-
gible. Another noteworthy shortcoming in the register
information in this study is that the indicator of time
after settlement in Sweden is based on the date when a
residence permit was granted, and not when actually en-
tering Sweden. As a result the asylum period was not in-
cluded when we calculated duration of residence, which
means that most individuals had resided in Sweden for a
longer period than estimated. The average waiting time
for asylum was about one year during the time of the
study, which indicates that the true time lapse in access
to care was even more protracted than shown by our re-
sults. The waiting time, however, was similar in the six
refugee study groups. Thus, differences in waiting time
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our analysis of differences between study groups [35].
Another shortcoming, is that we only had information
on the last time the individual received residence permit
in Sweden. It seems most unlikely, however, that the re-
immigration would be a common occurrence in these
Non-European refugees, bearing in mind that many refu-
gees come from countries that are still conflict-stricken and
that this would necessitate a new asylum application in
most cases. Finally, the Swedish Prescribed Drug Register
only holds information on drugs purchased at Swedish
pharmacies. It is not altogether unlikely that immigrants
may have other ways of obtaining prescribed drugs, illegally,
legally in other countries or through the internet. It seems
quite unlikely, however, that this would explain the time-
pattern of dispensed drugs in this study.
Conclusion
Psychotropic drug use is sometimes used as an indicator
of mental health problems in large populations in national
prescribed drug registers. The time dependent pattern of
psychotropic drug use in this study, and the large variation
of drug use between different refugee population implies
considerable caution in the interpretation of such studies,
unless the relation between psychotropic medication and
mental health has been investigated in that specific refugee
population in a longitudinal perspective.
The present study showed a low use of psychotropic
drugs during the first years after having received the per-
manent residency among newly settled refugees and their
families compared with the Swedish-born population, sug-
gesting barriers in access to adequate treatment. Psychi-
atric illness, such as depression and PTSD, are potentially
disabling diseases and may hamper a successful integra-
tion into the new society. Further studies are needed to
elucidate the barriers to mental health care for refugees so
that effective measures to improve access to mental health
services can be implemented.
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